Prostate Health
Total Prostate Specific Antigen
Free Prostate Specific Antigen
Interleukin-8
Monocyte Chemotactic Protein-1
Epidermal Growth Factor
Prostate Cancer Risk Score
published, combines
traditional TPSA and FPSA with a novel
combination of serum markers. This
innovative approach, helps triage patients
into “low-” and “high-risk” categories,
allowing general practitioners to improve
patient management in primary care and
potentially reduce unnecessary, invasive,
and costly treatments.